Study Assessing Pharmacokinetics and Bioavailability of Three Novel Triazine Compounds

NCT03436160 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

18

Enrollment

FED

Sponsor class

Conditions

Malaria

Interventions

DRUG: WR826647
DRUG: WR909388
DRUG: WR909390

Sponsor

U.S. Army Medical Research and Development Command

Collaborators

[object Object]